
Lantern Pharma Inc. (NASDAQ:LTRN) Q1 2025 Earnings Call Transcript
Lantern Pharma Inc. (NASDAQ:LTRN) Q1 2025 Earnings Call Transcript May 15, 2025 Lantern Pharma Inc. beats earnings expectations. Reported EPS is $-0.42, expectations were $-0.49. Operator: Good morning, and welcome to our First Quarter 2025 Earnings Call. …